Is a
Patent attributes
Patent Jurisdiction
Patent Number
Patent Inventor Names
P. Elizabeth Rakoczy0
Ian J. Constable0
Thomas W. Chalberg, Jr.0
Chooi-May Lai0
Date of Patent
June 26, 2018
0Patent Application Number
158516500
Date Filed
December 21, 2017
0Patent Citations Received
Patent Primary Examiner
Patent abstract
The present disclosure provides compositions and methods for the prevention or treatment of ocular neovascularization, such as AMD, in a human subject, by administering subretinally a pharmaceutical composition comprising a pharmaceutically effective amount of a vector comprising a nucleic acid encoding soluble Fms-related tyrosine kinase-1 (sFlt-1) protein to the human subject.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
